BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 19797703)

  • 1. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
    Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
    Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
    Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
    Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic acid induces allograft inflammatory factor-1 expression via a nitric oxide-related mechanism and increases neovascularization.
    Lee AW; Chen TL; Shih CM; Huang CY; Tsao NW; Chang NC; Chen YH; Fong TH; Lin FY
    J Agric Food Chem; 2010 Dec; 58(24):12941-9. PubMed ID: 21070071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia.
    Pfosser A; Thalgott M; Büttner K; Brouet A; Feron O; Boekstegers P; Kupatt C
    Cardiovasc Res; 2005 Feb; 65(3):728-36. PubMed ID: 15664400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
    Sugano M; Tsuchida K; Makino N
    Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
    Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
    Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
    Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
    de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA.
    Hiraoka K; Koike H; Yamamoto S; Tomita N; Yokoyama C; Tanabe T; Aikou T; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2003 Nov; 108(21):2689-96. PubMed ID: 14568901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
    Theurl M; Schgoer W; Albrecht-Schgoer K; Lener D; Wolf D; Wolf M; Demetz E; Tymoszuk P; Tancevski I; Fischer-Colbrie R; Franz WM; Marschang P; Kirchmair R
    Cardiovasc Res; 2015 Jan; 105(1):96-106. PubMed ID: 25377726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
    Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
    Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
    Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
    Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
    Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis.
    Sumi M; Sata M; Miura S; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):813-8. PubMed ID: 17272742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.